Pharmacokinetics, safety, and tolerability of ASP015K, a novel janus kinase inhibitor, in healthy volunteers

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2013
This article has no abstract
Epistemonikos ID: 47c4dbd8a9cb2bcc67ad7342f2a33fa8feef108b
First added on: Feb 15, 2022